Top Story

Prolactinoma increases CVD risk in men

Prolactinoma increases CVD risk in men
October 19, 2017

Men with prolactinoma are at higher risk for incident cardiovascular disease compared with women with prolactinoma and healthy men and women, according to findings published in Clinical Endocrinology.

Niki Karavitaki , MSc, PhD, FRCP, of the Institute of Metabolism and Systems Research at the University of Birmingham and Centre for Endocrinology, Diabetes and Metabolism at Birmingham Health Partners in the United Kingdom, and colleagues evaluated data from The Health Improvement Network (THIN) database on 2,233 adults with prolactinoma (1,822 women) and 10,355 matched controls (8,557 women) to determine whether the risk for incident CVD is increased in patients with prolactinoma. Mean age of women was 37.1 years and mean age of men was 47.3 years. Participants were observed for 6 years.

Imaging Analysis

Intraoperative MRI improves complete resection of pituitary macroadenoma

Endocrine Today, October 2017
Brooke Swearingen, MD; Stephanie L. Lee, MD, PhD, ECNU
A 63-year-old man was referred to the Massachusetts General Hospital Neuroendocrine & Pituitary Tumor Clinical Center for management of a pituitary macroadenoma. He…
In the Journals Plus

Craniopharyngioma increases risks for diabetes, all-cause mortality

October 6, 2017
Adults with craniopharyngioma, whether onset was during childhood or adulthood, have increased risks for developing diabetes, new intracranial tumors, all-cause…
In the Journals PlusPerspective

Hormone replacement before fertility treatment increases pregnancy chance in hypopituitarism

October 3, 2017
Women with childhood-onset combined pituitary hormone deficiencies have successful pregnancies when treated with adequate hormone replacement before ovarian stimulation…
More Headlines »

Practical Lipidology® (Volume 4): Focus on: LDL Reduction and PCSK9 Inhibition

This activity is supported by an educational grant from Amgen, Inc.

The reduction of low-density lipoprotein cholesterol (LDL-C) is recognized as the primary strategy for decreasing…
More »
Meeting News Coverage

VIDEO: Screening for Cushing's critical, complicated

May 20, 2015
More »
Resource Centers



Best of Obesity Forum® 2017

This activity is supported by an educational grant from Novo Nordisk, Inc.

The incidence of obesity has increased dramatically over the past 20 years and is considered to be an epidemic in the…
More »